526 Pharmacokinetic and Pharmacodynamic Analyses of PD-1 Blockade with Nivolumab at Varying Doses and Schedules Supports Administration at Markedly Reduced Dose and Frequency
Lisa M Tachiki,Haroldo Rodriguez Chevez,Carina Morningstar,Rian Alam,Allison Remington,Daniel S Hippe,Thomas Pulliam,Candice D Church,Keith T Schmidt,Vijaya Kumari Karra,Shin Foong Ngiow,Divij Mathew,Grete Ambrazeviciute,Maya Yousefiasl,William McCamy,Andrea Perdue,Julia Majovski,Evan Hall,John Thompson,Joshua Veatch,Scott S Tykodi,Sylvia Lee,Justin Taylor,Jordan Gauthier,Paul Nghiem,E John Wherry,William Figg,Shailender Bhatia
Regular and Young Investigator Award Abstracts（2024）
